Lexington, KY, July 22, 2008: MedPro Safety Products, Inc. (OTCBB: MPSP) has entered into two medical supply manufacturing agreements with Greiner Bio-One GmbH, a division of Greiner Bio-One International AG, an international manufacturer and supplier of medical products with locations in Austria, Germany, Hungary, United States and Brazil as well as a worldwide distribution network. The two agreements grant Greiner the right to manufacture, market and distribute MedPro’s tube-activated and skin-activated blood collection systems and its winged “butterfly” safety needle system. Each agreement extends for a six-year term from the commencement of initial commercial manufacturing of the applicable product. .
The agreement with Greiner for the exclusive right to manufacture, market and distribute our tube-activated blood collection system and our skin activated blood collection device supersedes and replaces our prior distribution agreement with Greiner for the tube-activated blood collection system.
Greiner also entered into an agreement with us for the exclusive right to manufacture, market and distribute our winged “butterfly” safety needle system on similar terms.
MedPro’s Chairman and Chief Executive Officer, Craig Turner, stated: “Greiner is a world-class company, specifically known for its dedication to providing superior product quality and services. We are particularly pleased to expand our relationship with Greiner, which we believe will accelerate global market access for our product, and global exposure for our Company.”
MedPro’s President and Chief Operating Officer, Walter Weller, stated: “These two agreements extend our relationship with Greiner and will bring our unique and proprietary passive needlestick avoidance technology to the market. We are very excited that Greiner has made a commitment to our blood collection safety devices to facilitate and complement its sale of blood collection tubes, equipment, and analytical services.”
Founded in 1995 and headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. (OTCBB: MPSP) has developed and acquired a portfolio of medical safety products incorporating proprietary needlestick prevention functionalities. For additional information, please refer to the ‘investor relations’ link on the Company’s website (www.medprosafety.com).
From time to time, MedPro makes forward-looking statements in its public disclosures, including statements relating to expected financial results, revenues that might be expected from its development and acquisition activities, financing plans, compliance with debt covenants and other risk factors, and various trends affecting the medical safety product industry. In MedPro’s filings under the federal securities laws, including its annual, periodic and current reports, the Company identifies important factors that could cause its actual results to differ materially from those anticipated in forward-looking statements. Please refer to the discussion of those factors in the Company’s filed reports. Statements related to expected financial results are as of this date only, and MedPro does not assume any responsibility to update these statements.